Literature DB >> 17662459

Estrogen receptor beta in the brain: from form to function.

Michael J Weiser1, Chad D Foradori, Robert J Handa.   

Abstract

Estrogens have numerous effects on the brain, both in adulthood and during development. These actions of estrogen are mediated by two distinct estrogen receptor (ER) systems, ER alpha (ERalpha) and ER beta (ERbeta). In brain, ERalpha plays a critical role in regulating reproductive neuroendocrine function and behavior, however, a definitive role for ERbeta in any neurobiological function has been slow in forthcoming. Clues to the function of ERbeta in the central nervous system can be gleaned from the neuroanatomical distribution of ERbeta and the phenotypes of neurons that express ERbeta. ERbeta immunoreactivity has been found in populations of GnRH, CRH, vasopressin, oxytocin and prolactin containing neurons in the hypothalamus. Utilizing subtype-selective estrogen receptor agonists can help determine the roles for ERbeta in non-reproductive behaviors in rat models. ERbeta-selective agonists exert potent anxiolytic activity when animals were tested in a number of behavioral paradigms. Consistent with this, ERbeta-selective agonists also inhibited the ACTH and corticosterone response to stress. In contrast, ERalpha selective agonists were found to be anxiogenic and correspondingly increased the hormonal stress response. Taken together, our studies implicate ERbeta as an important modulator of some non-reproductive neurobiological systems. The molecular and neuroanatomical targets of estrogen that are mediated by ERbeta remain to be determined. A number of splice variants of ERbeta mRNA have been reported in brain tissue. Imaging of eGFP labeled chimeric receptor proteins transfected into cell lines shows that ERbeta splice variation can alter trafficking patterns and function. The originally described ERbeta (herein termed ERbeta1) is characterized by possessing a high affinity for estradiol. Similar to ERalpha, it is localized in the nucleus and is trafficked to nuclear sites termed "hyperspeckles" following ligand binding. In contrast, ERbeta2 contains an 18 amino acid insert within the ligand-binding domain and as a result can be best described as a low affinity form of ERbeta. A delta3 (delta3) variant of ERbeta has a deletion of the 3rd exon (coding for the second half of the DNA-binding domain) and as a result does not bind an estrogen response element in DNA. delta3 variants are trafficked to a unique low abundance and larger nuclear site following ligand binding. A delta4 (delta4) variant lacks exon 4 and as a result is localized to the cytoplasm. The amount of individual splice variant mRNAs varies depending upon brain region. Examination of neuropeptide promoter regulation by ERbeta splice variants demonstrates that ERbeta functions as a constitutively active transcription factor. Moreover, it appears that splice variation of ERbeta alters its ability to regulate transcription in a promoter-dependent and ligand-dependent fashion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17662459      PMCID: PMC2374745          DOI: 10.1016/j.brainresrev.2007.05.013

Source DB:  PubMed          Journal:  Brain Res Rev        ISSN: 0165-0173


  126 in total

1.  Identification of a splice variant of the rat estrogen receptor beta gene.

Authors:  S Chu; P J Fuller
Journal:  Mol Cell Endocrinol       Date:  1997-09-19       Impact factor: 4.102

2.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

3.  Expression of estrogen receptor-beta protein and mRNA in the cerebellum of the rat.

Authors:  R H Price; R J Handa
Journal:  Neurosci Lett       Date:  2000-07-14       Impact factor: 3.046

4.  A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action.

Authors:  K Maruyama; H Endoh; H Sasaki-Iwaoka; H Kanou; E Shimaya; S Hashimoto; S Kato; H Kawashima
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

5.  The Octopus vulgaris estrogen receptor is a constitutive transcriptional activator: evolutionary and functional implications.

Authors:  June Keay; Jamie T Bridgham; Joseph W Thornton
Journal:  Endocrinology       Date:  2006-05-11       Impact factor: 4.736

6.  An anxiolytic action of oxytocin is enhanced by estrogen in the mouse.

Authors:  M M McCarthy; C H McDonald; P J Brooks; D Goldman
Journal:  Physiol Behav       Date:  1996-11

7.  The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.

Authors:  P Webb; P Nguyen; C Valentine; G N Lopez; G R Kwok; E McInerney; B S Katzenellenbogen; E Enmark; J A Gustafsson; S Nilsson; P J Kushner
Journal:  Mol Endocrinol       Date:  1999-10

8.  Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test.

Authors:  Alicia A Walf; Madeline E Rhodes; Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2004-07       Impact factor: 3.533

9.  Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy.

Authors:  E W Bingaman; D J Magnuson; T S Gray; R J Handa
Journal:  Neuroendocrinology       Date:  1994-03       Impact factor: 4.914

10.  Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats.

Authors:  L H Burgess; R J Handa
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

View more
  73 in total

1.  How reward and emotional stimuli induce different reactions across the menstrual cycle.

Authors:  Michiko Sakaki; Mara Mather
Journal:  Soc Personal Psychol Compass       Date:  2012-01-01

2.  The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease.

Authors:  Gurdeep Marwarha; Turk Rhen; Trevor Schommer; Othman Ghribi
Journal:  J Neurochem       Date:  2011-10-24       Impact factor: 5.372

3.  Differential control of sex differences in estrogen receptor α in the bed nucleus of the stria terminalis and anteroventral periventricular nucleus.

Authors:  D A Kelly; M M Varnum; A A Krentzel; S Krug; N G Forger
Journal:  Endocrinology       Date:  2013-09-11       Impact factor: 4.736

Review 4.  Estrogen receptors and the regulation of neural stress responses.

Authors:  Robert J Handa; Shaila K Mani; Rosalie M Uht
Journal:  Neuroendocrinology       Date:  2012-09-14       Impact factor: 4.914

5.  Ovarian steroids modulate leu-enkephalin levels and target leu-enkephalinergic profiles in the female hippocampal mossy fiber pathway.

Authors:  Annelyn Torres-Reveron; Sana Khalid; Tanya J Williams; Elizabeth M Waters; Carrie T Drake; Bruce S McEwen; Teresa A Milner
Journal:  Brain Res       Date:  2008-07-26       Impact factor: 3.252

6.  Improving Estrogenic Compound Screening Efficiency by Using Self-Modulating, Continuously Bioluminescent Human Cell Bioreporters Expressing a Synthetic Luciferase.

Authors:  Tingting Xu; Andrew Kirkpatrick; Jody Toperzer; Steven Ripp; Dan Close
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

Review 7.  Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones.

Authors:  S Bradley King; Donna J Toufexis; Sayamwong E Hammack
Journal:  Stress       Date:  2017-06-14       Impact factor: 3.493

Review 8.  Consequences of early experiences and exposure to oxytocin and vasopressin are sexually dimorphic.

Authors:  C Sue Carter; Ericka M Boone; Hossein Pournajafi-Nazarloo; Karen L Bales
Journal:  Dev Neurosci       Date:  2009-06-17       Impact factor: 2.984

Review 9.  L-Type Calcium Channels Modulation by Estradiol.

Authors:  Nelson E Vega-Vela; Daniel Osorio; Marco Avila-Rodriguez; Janneth Gonzalez; Luis Miguel García-Segura; Valentina Echeverria; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-08-15       Impact factor: 5.590

Review 10.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.